Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trial
| Autor: | Selcuk Muhtaroglu, Ferda, Belgen Kaygisiz, Beliz, Usar Incirli, Sila, Kahraman, Turhan |
|---|---|
| Zdroj: | In Journal of Clinical Neuroscience November 2023 117:136-142 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect